SEC-sourced researchBeta
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Company comparison ↗
Data passport
- CIK
- 0000818686
- Exchange
- NYSE
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Sep 22, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 15,846,000,000.0000 | Feb 3, 2026 |
| December 2024 | 16,544,000,000.0000 | Feb 3, 2026 |
| December 2025 | 17,258,000,000.0000 | Feb 3, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 17,258,000,000.0000 | 1,410,000,000.0000 | 1,649,000,000.0000 | 40,748,000,000.0000 | 32,834,000,000.0000 | Feb 3, 2026 |
| December 2024 | 16,544,000,000.0000 | -1,639,000,000.0000 | 1,247,000,000.0000 | 39,326,000,000.0000 | 33,606,000,000.0000 | Feb 3, 2026 |
| December 2023 | 15,846,000,000.0000 | -559,000,000.0000 | 1,368,000,000.0000 | — | — | Feb 3, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $17.26B | December 2025 | Feb 3, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $16.54B | December 2024 | Feb 3, 2026 | 10-K |
| Net incomeNetIncomeLoss | $1.41B | December 2025 | Feb 3, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $1.65B | December 2025 | Feb 3, 2026 | 10-K |
| Total assetsAssets | $40.75B | December 2025 | Feb 3, 2026 | 10-K |
| Total liabilitiesLiabilities | $32.83B | December 2025 | Feb 3, 2026 | 10-K |
New filings
- 4TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 22, 2026 · Other
- 4TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 22, 2026 · Other
- 144TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 21, 2026 · Other
- 144TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 18, 2026 · Other
- 8-KTEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 16, 2026 · Current event
- 8-KTEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 14, 2026 · Current event
- 8-A12B/ATEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 14, 2026 · Other
- 25-NSETEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 14, 2026 · Other
- 424B5TEVJF · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 11, 2026 · Other
- 8-KTEVJF · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 11, 2026 · Current event
- FWPTEVJF · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 10, 2026 · Other
- FWPTEVJF · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 10, 2026 · Other
- 424B5TEVJF · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 8, 2026 · Other
- 8-KTEVJF · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 3, 2026 · Current event
- 8-KTEVJF · TEVA PHARMACEUTICAL INDUSTRIES LTDSep 3, 2026 · Current event
- 10-KTEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDFeb 3, 2026 · Annual